Philogen
PHIL | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0005373789 (+1 more)
- LEI:
- 81560009EA1577917768
- Country:
- Italy
- Address:
- PIAZZA LA LIZZA, 7, 53100 SIENA
- Website:
- https://www.philogen.com
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Founded in 1996, Philogen is an Italian-Swiss biotechnology company engaged in the discovery and development of biopharmaceutical products for the treatment of life-threatening conditions. Philogen Group mainly discovers and develops targeted anti-cancer drugs, exploiting high-affinity ligands for tumor markers. These ligands – namely human monoclonal antibodies or small molecules – are identified through Antibody Phage Display Libraries and DNA-Encoded Chemical Libraries technologies. The main therapeutic strategy of the Group for the treatment of these diseases is the so-called “tumor targeting”.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Philogen.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-07 16:50 |
Transaction in Own Shares
2025 07 07 - CS settimanale acquisto azioni proprie
|
Italian | 153.0 KB | |
| 2025-07-07 12:08 |
Regulatory News Service
Allegato 3F
|
Italian | 26.7 KB | |
| 2025-06-30 17:04 |
Transaction in Own Shares
2025 06 30 - CS settimanale acquisto azioni proprie
|
Italian | 181.7 KB | |
| 2025-06-25 12:29 |
Legal Proceedings Report
Philogen Provides Update on Marketing Authorization Application for Nidlegy™ in…
|
English | 180.5 KB | |
| 2025-06-11 01:34 |
Regulatory News Service
Press Release Licenza OncoACP3 (Price Sensitive)
|
Italian | 225.0 KB | |
| 2025-06-03 13:40 |
Transaction in Own Shares
2025 06 03 - CS settimanale acquisto azioni proprie
|
Italian | 144.1 KB | |
| 2025-05-26 17:46 |
Registration Form
Statuto
|
Italian | 261.6 KB | |
| 2025-05-26 17:24 |
Post-Annual General Meeting Information
Deposito del Verbale dell'Assemblea degli Azionisti
|
Italian | 131.0 KB | |
| 2025-05-26 17:22 |
Pre-Annual General Meeting Information
Verbale dei lavori dell'Assemblea Ordinaria e Straordinaria degli Azionisti
|
Italian | 30.4 MB | |
| 2025-05-26 15:09 |
Transaction in Own Shares
2025 05 26 - CS settimanale acquisto azioni proprie
|
Italian | 147.5 KB | |
| 2025-05-19 12:24 |
Transaction in Own Shares
2025 05 19 - CS settimanale acquisto azioni proprie
|
Italian | 130.7 KB | |
| 2025-05-12 15:04 |
Transaction in Own Shares
2025 05 12 - CS settimanale acquisto azioni proprie
|
Italian | 141.2 KB | |
| 2025-05-07 10:30 |
Director's Dealing
Allegato 3F
|
Italian | 27.5 KB | |
| 2025-05-06 18:56 |
Post-Annual General Meeting Information
Il Consiglio di Amministrazione approva la posizione finanziaria netta relativa…
|
Italian | 259.8 KB | |
| 2025-04-29 18:05 |
Post-Annual General Meeting Information
Comunicato stampa Assemblea 29 aprile 2025
|
Italian | 209.6 KB |
Automate Your Workflow. Get a real-time feed of all Philogen filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Philogen via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |